PSCHvsARKGETF Comparison
VS
Invesco S&P SmallCap Health Care ETF (PSCH) belongs to the US Health Care segment. ARK Genomic Revolution ETF (ARKG) is part of the BioTech & Genomics segment. Both ETFs have the same top 1 sector exposures: Healthcare. PSCH is less expensive with a Total Expense Ratio (TER) of 0.29%, versus 0.75% for ARKG. PSCH is up 23.3% year-to-date (YTD) with -$1M in YTD flows. ARKG performs better with 65% YTD performance, and +$99M in YTD flows. Run a side-by-side ETF comparison of PSCH and ARKG below, and assess how they stack up in performance, liquidity, risk, exposure, holdings, and more, helping you select the best ETF for your investments.
Find out how industry players manage ETF portfolios. Discover our library of Model portfolios
PSCH vs ARKG performance and flow charts
Performance
Cumulative Flows
Historic performance and flows
Data as of 10/26/2026
| 1M | 3M | YTD | 1Y | 3Y | 5Y | ||
|---|---|---|---|---|---|---|---|
| Perf. | PSCH ARKG | +1.90%-5.34% | +2.74%+24.16% | +23.30%+65.00% | +27.01%+53.44% | +55.14%+104.58% | -8.77%-36.03% |
| Flows | PSCH ARKG | -$11M-$32M | +$9M+$52M | -$1M+$99M | -$921K+$29M | -$102M-$398M | -$210M-$1.99B |
Volatility and drawdown
| 3M | 1Y | 3Y | 5Y | ||
|---|---|---|---|---|---|
| Volatility | PSCH ARKG | +17.03%+49.20% | +19.47%+44.31% | +21.78%+44.74% | +22.92%+46.82% |
| Max drawdown | PSCH ARKG | -8.61%-17.81% | -15.36%-27.52% | -22.80%-46.41% | -45.76%-76.56% |
| Max drawdown duration | PSCH ARKG | 68d18d | 168d126d | 488d882d | 1813d1814d |
Trading data
PSCH | ARKG | |
Last sale 10/26/2026 at 1:30 PM | $54.35 | $48.72 |
| Previous close 10/26/2026 | $54.00 | $48.16 |
| Consolidated volume 10/26/2026 | ||
| Average volume 30 days | ||
| Average discount or premium 30 days | ||
| Average Bid/Ask spread 30 days |
Replication quality
Data as of September 30, 2026
1-year trailing difference
Create an account to view replication metrics
Join for free
ARKG
is actively managed and doesn’t replicate an indexPSCH | ARKG | |
|---|---|---|
| Tracking error | ||
| Tracking difference | ||
| 1 year cumulative return difference | ||
| Best | ||
| Worst | ||
| Daily return difference | ||
| Average | ||
| Worst | ||
Advertisement
Main metrics
Last update 10/26/2026 at 1:30 PM
Live
Closed
PSCH | ARKG | |
|---|---|---|
| Last price | $54.35 | $48.72 |
| 1D performance | +0.65% | +1.16% |
| AuM | $175.03 M | $2.03 B |
| E/R | 0.29% | 0.75% |
Characteristics
PSCH | ARKG | |
|---|---|---|
| Management strategy | Passive | Active |
| Provider | Invesco | Ark Investment |
| Benchmark | S&P SmallCap 600 Capped Health Care Index | - |
| N° of holdings | 69 | 31 |
| Asset class | Equities | - |
| Trailing 12m distribution yield | Join | Join |
| Inception date | April 7, 2010 | April 2, 2019 |
| ESG | No | No |
Advertisement
Exposure
Countries
PSCH
USA
94.93%
Other
5.07%
ARKG
USA
88.62%
Other
11.38%
Sectors
PSCH
Healthcare
100%
Other
0%
ARKG
Healthcare
97.89%
Other
2.11%
Advertisement
Diversification
PSCH
Total weight of top 15 holdings out of 15
48.62%
ARKG
Total weight of top 15 holdings out of 15
74.64%
Top 15 holdings
Data as of August 31, 2026
PSCH
Corcept Therapeutics, Inc.
5.61%
Glaukos Corp.
5.37%
Protagonist Therapeutics, Inc.
4.54%
Alkermes Plc
4.09%
TG Therapeutics, Inc.
3.69%
Teleflex, Inc.
3.06%
PTC Therapeutics, Inc.
2.99%
Ligand Pharmaceuticals, Inc.
2.87%
Merit Medical Systems, Inc.
2.68%
RadNet, Inc.
2.68%
Liquidia Corp.
2.47%
ICU Medical, Inc.
2.20%
Indivior Pharmaceuticals, Inc.
2.16%
Integer Holdings Corp.
2.14%
Concentra Group Holdings Parent, Inc.
2.07%
ARKG
10X Genomics, Inc.
9.58%
Twist Bioscience Corp.
9.13%
Tempus AI, Inc.
7.91%
CRISPR Therapeutics AG
6.10%
Personalis, Inc.
5.93%
Absci Corp.
4.88%
Natera, Inc.
4.06%
Illumina, Inc.
4.04%
Eli Lilly & Co.
3.86%
CareDx, Inc.
3.85%
Guardant Health, Inc.
3.81%
Beam Therapeutics, Inc.
3.56%
Compass Pathways Plc
3.17%
Recursion Pharmaceuticals, Inc.
2.44%
Adaptive Biotechnologies Corp.
2.32%
Frequently asked questions about PSCH and ARKG
How have the PSCH and ARKG ETFs performed in 2026?
As of October 26, 2026, PSCH is up 23.3% year-to-date (YTD), while ARKG has returned 65%. That puts ARKG better performer ahead so far this year.
Which ETF is attracting more investor money: PSCH or ARKG?
Year-to-date, the PSCH ETF saw -$1M in flows, compared to +$99M for ARKG.
Which ETF is more volatile: PSCH or ARKG?
Over the past year, PSCH had a volatility of 19.47%, while ARKG experienced 44.31%.
Which ETF is bigger: PSCH or ARKG?
As of October 26, 2026, PSCH holds $175.03 M in assets under management (AUM), while ARKG manages $2.03 B.
What sectors do the PSCH and ARKG ETFs invest in?
PSCH leans toward sectors like Healthcare. Meanwhile, ARKG focuses on Healthcare.
What are the top holdings of the PSCH ETF and ARKG ETF?
PSCH top holdings include Corcept Therapeutics, Inc., Glaukos Corp. and Protagonist Therapeutics, Inc.. ARKG holds in its top three: 10X Genomics, Inc., Twist Bioscience Corp. and Tempus AI, Inc..
Which ETF is more diversified: PSCH or ARKG?
PSCH holds 69 securities with 48.62% of its assets in the top 15. ARKG has 31 securities and a top 15 weight of 74.64%.
Advertisement
Latest news about PSCH & ARKG
The Weekly ETF Market Monitor (October 19-23, 2026)
October 26, 2026
ARKG
Biotech ETFs – Investing in Health Innovation
July 21, 2022
ARKG
Advertisement
